AVTX icon

Avalo Therapeutics
AVTX

34 hedge funds and large institutions have $66.1M invested in Avalo Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

3% more funds holding

Funds holding: 33 → 34 (+1)

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.21M
2
+$4.17M
3
+$2.51M
4
AAA
Affinity Asset Advisors
New York
+$852K
5
AI
Allostery Investments
Connecticut
+$271K

Top Sellers

1
-$6.17M
2
-$1.22M
3
-$1.11M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$446K
5
HF
HRT Financial
New York
-$237K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$2K
SS
27
SBI Securities
Japan
$176
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$32
Osaic Holdings
29
Osaic Holdings
Arizona
$16
Group One Trading
30
Group One Trading
Illinois
$16
PA
31
Parallel Advisors
California
$8
KFI
32
Key Financial Inc
Pennsylvania
$8
AWM
33
Activest Wealth Management
Florida
$8
BFM
34
Boothbay Fund Management
New York
–
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
–
Marshall Wace
36
Marshall Wace
United Kingdom
–
TRCT
37
Tower Research Capital (TRC)
New York
–
1
2